Jubilant Life Sciences today posted a 56.75 per cent decline in consolidated net profit at Rs 42.73 crore for the fourth quarter of 2014-15 financial year ended March 31.
The company had posted a net profit of Rs 98.81 crore during the same period of previous fiscal.
Net sales of the company declined to Rs 1,523.25 crore for the fourth quarter, as compared to Rs 1,551.62 crore during the same period of previous fiscal, Jubilant Life Sciences said in a statement.
Also Read
For the year ended March 31, the company posted a consolidated net loss of Rs 57.76 crore, as against a net profit of Rs 109.04 crore during the previous fiscal.
Net sales of the company, however, rose to Rs 5,776.14 crore, from Rs 5,721.61 crore during the 2013-14 fiscal.
The company's board, which met today, recommended a dividend of Rs 3 per equity share of Re 1 each for the year ended March 31, 2015.
The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the company, will be paid on or before September 30, 2015.
Jubilant Life Sciences shares today ended at Rs 170.80 apiece on the BSE, up 2.18 per cent from previous close.
